HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

procyanidin B1

Networked: 9 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	An, Hailong: 1 article (01/2020)
2.	Chen, Yafei: 1 article (01/2020)
3.	Ma, Biao: 1 article (01/2020)
4.	Na, Wenjing: 1 article (01/2020)
5.	Shi, Sai: 1 article (01/2020)
6.	Zhan, Yong: 1 article (01/2020)
7.	Zhang, Hailin: 1 article (01/2020)
8.	Gao, Dongna: 1 article (01/2019)
9.	Li, Wenyang: 1 article (01/2019)
10.	Ma, Xiaochi: 1 article (01/2019)

Related Diseases

1.	Non-alcoholic Fatty Liver Disease 02/29/2012 - "As mentioned above, Flavangenol showed a significant suppressive effect in the NAFLD model, and it was suggested that the molecular mechanism is induction of fatty acid oxidation, with the effect mainly attributed to procyanidin B1."
2.	Vesicular Stomatitis 08/11/2010 - "Procyanidin B1 (PB1), a dimer of (-)-epicatechin and (+)-catechin, purified from Cinnamomi cortex, inhibits infection by vesicular stomatitis virus and HCV pseudotype virus in Huh-7 cells, with 50% effective concentrations of 29 and 15 microM, respectively. "
3.	Neoplasms (Cancer) 01/01/2020 - "Our data showed that 15 mg/kg Procyanidin B1 can significantly suppress the growth of the tumor (HepG2) with an inhibition rate of about 60.25%. " 01/01/2020 - "Next, we assayed the tumor suppressing effect of Procyanidin B1 on cell line-derived xenograft mouse model. " 01/01/2020 - "The present work indicated that Procyanidin B1 is a proming liver cancer anti-tumor drug, and also confirmed that Kv10.1 can serve as a potential, tumor-specific drug target."
4.	Liver Neoplasms (Liver Cancer) 01/01/2020 - " addition, Procyanidin B1 inhibits migration and proliferation of liver cancer cells (HuH-7 cells, HepG2 cells) through inhibiting Kv10.1, but not in Kv10.1 negatively expressed cell lines. " 01/01/2020 - "The present work indicated that Procyanidin B1 is a proming liver cancer anti-tumor drug, and also confirmed that Kv10.1 can serve as a potential, tumor-specific drug target."
5.	Inflammation (Inflammations) 01/01/2019 - "We previously reported that the phenolic compound procyanidin B1 inhibits inflammation by suppressing the p38 MAPK signaling pathway. "

Related Drugs and Biologics

1.	Catechin (Z 7300)
2.	procyanidin B2
3.	Polyphenols
4.	p38 Mitogen-Activated Protein Kinases
5.	Dextran Sulfate
6.	Proline (L-Proline)
7.	Fatty Acids (Saturated Fatty Acids)
8.	Cinnamates
9.	Antineoplastic Agents (Antineoplastics)
10.	flavangenol

Related Therapies and Procedures

1.	Therapeutics